Clinical Trials Directory

Trials / Completed

CompletedNCT03317782

NoL Index Variations Before and After a Stellate Ganglion Block

Evaluation of NoL Index Variations After a Painful Stimulus Before and After a Stellate Ganglion Block in Patients With Upper Extremity Complex Regional Pain Syndrome: a Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Maisonneuve-Rosemont Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate and compare the NoL index variations after a painful physiotherapy exercise in patients with upper limb CRPS, before and after a stellate ganglion block.

Conditions

Interventions

TypeNameDescription
DEVICENoL indexThe NoL/PMD-200 (Medasense Biometrics Ltd, Ramat Yishai, Israel) is a multi-parameter index (0-100) that incorporates heart rate, heart rate variability (0.15-0.4 Hz band power), plethysmograph wave amplitude, skin conductance level, number of skin conductance fluctuations (NSCF), and their time derivatives9 using a non-linear regression technique. A higher index indicates higher nociception, and an index \<20 indicates adequate analgesia.

Timeline

Start date
2017-10-23
Primary completion
2018-12-18
Completion
2019-04-04
First posted
2017-10-23
Last updated
2019-09-16

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03317782. Inclusion in this directory is not an endorsement.